Literature DB >> 32430659

Neuroprotective effects of Fomes officinalis Ames polysaccharides on Aβ25-35-induced cytotoxicity in PC12 cells through suppression of mitochondria-mediated apoptotic pathway.

Ayijiang Habaike1, Mirensha Yakufu1, Yuanyuan Cong1, Yimin Gahafu1, Zhen Li1, Palida Abulizi2.   

Abstract

Aggregation of Aβ is a pathological hallmark of Alzheimer's disease (AD). The purpose of this study was to identify the protective roles of different polysaccharide components in Fomes officinalis Ames polysaccharides (FOAPs) against Aβ25-35-induced neurotoxicity in PC12 cells. Different doses of FOAPs components (i.e. FOAPs-a and FOAPs-b) were added to PC12 cells about 2 h before β-amyloid protein fragment 25-35 (Aβ25-35) exposure. The AD cellular model of PC12 cells was established using Aβ25-35. Then the PC12 cells were divided into 9 groups including: control group, Donepezil hydrochloride (DHCL) group, model group treated using 40 μM Aβ25-35, followed by FOAPs-a and FOAPs-b interference (50, 100 and 200 μg/mL). The mitochondrial reactive oxygen species (ROS), ATP, superoxide dismutase (SOD), malondialdehyde (MDA), lactate dehydrogenase (LDH) and mitochondrial membrane potential (MMP) were determined by commercial kits. The Cytochrome C, Bcl-2 and Bax expressions in the mitochondria and cytosol was determined by using Western blot analysis. FOAPs-a and FOAPs-b could significantly inhibit the LDH release, MDA level and the over accumulation of ROS induced by Aβ25-35 in PC12 cells in a dose-dependent manner. They could also effectively prevent Aβ25-35-stimulated cytotoxicity, which involved in attenuating cell apoptosis, increasing the ratio of Bcl-2/Bax and inhibiting Cytochrome C release from mitochondria to cytosol in PC12 cells. Moreover, FOAPs-a and FOAPs-b significantly alleviated mitochondrial dysfunction by regulating the MMP, as well as promoting the mitochondrial ATP synthesis. FOAPs-a and FOAPs-b played neuroprotective roles against Aβ25-35-induced cytotoxicity in PC12 cells through suppressing the mitochondria-mediated apoptotic pathway.

Entities:  

Keywords:  Aβ25–35; Fomes officinalis Ames polysaccharides; Mitochondrial dysfunction; Oxidative stress; PC12 cells

Year:  2020        PMID: 32430659      PMCID: PMC7450017          DOI: 10.1007/s10616-020-00400-z

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  22 in total

1.  Valproic acid attenuates Aβ25-35-induced neurotoxicity in PC12 cells through suppression of mitochondria-mediated apoptotic pathway.

Authors:  Li Zhao; Laiqing Zhu; Xiaoqian Guo
Journal:  Biomed Pharmacother       Date:  2018-06-26       Impact factor: 6.529

2.  The Neuroprotective Effects of Decursin Isolated from Angelica gigas Nakai Against Amyloid β-Protein-Induced Apoptosis in PC 12 Cells via a Mitochondria-Related Caspase Pathway.

Authors:  Li Li; Jikun Du; Liyi Zou; Haishan Xia; Tie Wu; Yongho Kim; Yongwoo Lee
Journal:  Neurochem Res       Date:  2015-06-16       Impact factor: 3.996

3.  Dysfunction of mitochondria: Implications for Alzheimer's disease.

Authors:  Benedict C Albensi
Journal:  Int Rev Neurobiol       Date:  2019-03-26       Impact factor: 3.230

4.  α-bisabolol β-D-fucopyranoside as a potential modulator of β-amyloid peptide induced neurotoxicity: An in vitro &in silico study.

Authors:  Mahalingam Jeyakumar; Sethuraman Sathya; Soniya Gandhi; Prabhakarrao Tharra; Venkatesan Suryanarayanan; Sanjeev Kumar Singh; Beeraiah Baire; Kasi Pandima Devi
Journal:  Bioorg Chem       Date:  2019-04-19       Impact factor: 5.275

5.  Activation of anti-oxidant of curcumin pyrazole derivatives through preservation of mitochondria function and Nrf2 signaling pathway.

Authors:  Liping Liao; Jinguo Shi; Caibao Jiang; Liantao Zhang; Lisi Feng; Jiayong Liu; Jingxia Zhang
Journal:  Neurochem Int       Date:  2019-02-13       Impact factor: 3.921

Review 6.  On the central role of mitochondria dysfunction and oxidative stress in Alzheimer's disease.

Authors:  Tobore Onojighofia Tobore
Journal:  Neurol Sci       Date:  2019-04-13       Impact factor: 3.307

7.  Mesenchymal stem cells-conditioned medium protects PC12 cells against 2,5-hexanedione-induced apoptosis via inhibiting mitochondria-dependent caspase 3 pathway.

Authors:  Shuang-Yue Li; Yuan Qi; Shu-Hai Hu; Feng-Yuan Piao; Huai Guan; Zhe-Min Wang; Ruo-Lin Chen; Shuang Liu
Journal:  Toxicol Ind Health       Date:  2016-07-10       Impact factor: 2.273

8.  The First Generation of iPSC Line from a Korean Alzheimer's Disease Patient Carrying APP-V715M Mutation Exhibits a Distinct Mitochondrial Dysfunction.

Authors:  Ling Li; Jee Hoon Roh; Hee Jin Kim; Hyun Jung Park; Minchul Kim; Wonyoung Koh; Hyohoon Heo; Jong Wook Chang; Mahito Nakanishi; Taeyoung Yoon; Duk L Na; Jihwan Song
Journal:  Exp Neurobiol       Date:  2019-05-14       Impact factor: 3.261

9.  Suppression of Alzheimer's Disease-Like Pathology Progression by Mitochondria-Targeted Antioxidant SkQ1: A Transcriptome Profiling Study.

Authors:  Natalia A Stefanova; Nikita I Ershov; Nataliya G Kolosova
Journal:  Oxid Med Cell Longev       Date:  2019-07-15       Impact factor: 6.543

10.  Coniferaldehyde attenuates Alzheimer's pathology via activation of Nrf2 and its targets.

Authors:  Yaqiong Dong; Tessandra Stewart; Lidan Bai; Xue Li; Ting Xu; Jeffrey Iliff; Min Shi; Danfeng Zheng; Lan Yuan; Taotao Wei; Xiaoda Yang; Jing Zhang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more
  2 in total

1.  Protective Effect of Fucoidan against MPP+-Induced SH-SY5Y Cells Apoptosis by Affecting the PI3K/Akt Pathway.

Authors:  Huaide Liu; Jing Wang; Quanbin Zhang; Lihua Geng; Yue Yang; Ning Wu
Journal:  Mar Drugs       Date:  2020-06-25       Impact factor: 5.118

Review 2.  Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases.

Authors:  Manel Dhahri; Mawadda Alghrably; Hamdoon A Mohammed; Syed Lal Badshah; Noreen Noreen; Fouzi Mouffouk; Saleh Rayyan; Kamal A Qureshi; Danish Mahmood; Joanna Izabela Lachowicz; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Pharmaceutics       Date:  2021-12-21       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.